Effect of SA4503, a novel σ1 receptor agonist, against glutamate neurotoxicity in cultured rat retinal neurons

European Journal of Pharmacology

Volumn 342, Issue 1, 1998, Pages 105-111

  Senda, Toshihiko ^a   Mita, Shiro ^a   Kaneda, Katsuyuki ^b   Kikuchi, Masashi ^b   Akaike, Akinori ^b  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

1 Receptor subtype; (+) Pentazocine; Glutumate; Retinal cell culture; SA4503

Indexed keywords

1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; DIZOCILPINE; GLUTAMIC ACID; OPIATE AGONIST; PENTAZOCINE; RECEPTOR SUBTYPE; SIGMA 1 OPIATE RECEPTOR; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; FETUS; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA NERVE CELL;

ANALGESICS, OPIOID; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GABA ANTAGONISTS; GLUTAMIC ACID; NEURONS; PENTAZOCINE; PIPERAZINES; RATS; RECEPTORS, SIGMA; RETINA;

EID: 0032545727     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01450-7     Document Type: Article

References (60)

1. Abele A.E., Scholz K.P., Scholz W.K., Miller R.J. Excitotoxicity induced by enhanced excitatory neurotransmission in cultured hippocampal pyramidal neurons. Neuron. 2:1990;413-419.
2. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of the extracellular concentrations of glutamate and aspartate in the rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
3. Bloomfield S.A., Dowling J.E. Roles of aspartate and glutamate in synaptic transmission in rabbit retina. II. Inner plexiform layer. J. Neurophysiol. 53:1985;714-725.
4. 3H ]-Pentazocine: A potent and highly selective benzomorphan-based probe for sigma-1 receptors Mol. Neuropharmacol. 3:1993;117-126.
5. Brandon C., Lam D.M.-K. L-Glutamic acid: A neurotransmitter candidate for cone photoreceptors in human and rat retinas. Proc. Natl. Acad. Sci. USA. 80:1983;5117-5121.
6. 1 receptors Eur. J. Pharmacol. (Mol. Pharmacol. Sect.). 266:1994;131-138.
7. 1 binding sites in guinea pig brain. Eur. J. Pharmacol. 251:1994;R1-R2.
8. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Ann. Rev. Neurosci. 13:1990;171-182.
9. Davanger S., Ottersen O.P., Storm-Mathisen J. Glutamate, GABA, and glycine in the human retina. J. Comp. Neurol. 311:1991;483-494.
10. 3H ]-(+)-pentazocine, a highly potent and selective radioligand for σ receptors FEBS Lett. 251:1989;53-58.
11. Debonnel G., De Montigny C. Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: Possible implications for the treatment of psychiatric disorders. Life Sci. 58:1996;721-734.
12. DeCoster M.A., Klette K.L., Knight E.S., Tortella F.C. σ Receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res. 671:1995;45-53.
13. Dixon D.B., Copenhagen D.R. Two types of glutamate receptors differentially excite amacrine cells in the tiger salamander retina. J. Physiol. 49:1992;589-606.
14. Ei-Asrar A.M.A., Morse P.H., Maimone D., Torczynski E., Reder A.T. MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate. Invest. Ophthalmol. Vis. Sci. 33:1992;3463-3468.
15. Fletcher E.J., Church J., Abdel-Hamid K., MacDonald J.F. Blockade by sigma site ligands of N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurons. Br. J. Pharmacol. 116:1995;2791-2800.
16. Foster A.C., Gill R., Woodruff G.N. Neuroprotective effects of MK-801 in vivo: Selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. J. Neurosci. 8:1988;4745-4754.
17. 3H ]dopamine release from rat striatal slices by sigma receptor ligands J. Pharmacol. Exp. Ther. 271:1994;212-219.
18. Gonzalez-Alvear G.M., Werling L.L. Sigma receptor regulation of norepinephrine release from rat hippocampal slices. Brain Res. 673:1995;61-69.
19. Gotti B., Benavides J., MacKenzie E.T., Scatton B. The pharmacotherapy of focal cortical ischaemia in the mouse. Brain Res. 522:1990;290-307.
20. Itzhak Y. Multiple affinity binding states of the sigma receptor: Effect of GTP-binding protein-modifying agents. Mol. Pharmacol. 36:1989;512-517.
21. Itzhak, Y., 1994. Multiple sigma binding sites in the brain. In: Itzhak, Y., (Ed.), Sigma Receptors. Academic Press, San Diego, CA, pp. 113-137.
22. Johnson N.F. Effects of acute ischemia on the structure of the rabbit retina. Trans. Ophthalmol. Sci. UK. 94:1974;394-405.
23. Kashii S., Takahashi M., Mandai M., Shimizu H., Honda Y., Sasa M., Ujihara H., Tamura Y., Yokota T., Akaike A. Protective action of dopamine against glutamate neurotoxicity in the retina. Invest. Ophthalmol. Vis. Sci. 35:1994;685-695.
24. Kikuchi M., Kashii S., Honda Y., Ujihara H., Sasa M., Tamura Y., Akaike A. Protective action of zinc against glutamate neurotoxicity in cultured retinal neurons. Invest. Ophthalmol. Vis. Sci. 36:1995;2048-2053.
25. Lockhart B.P., Soulard P., Benicourt C., Privat A., Junien J.-L. Distinct neuroprotective profiles for σ ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res. 675:1995;110-120.
26. Louzada-Junior P., Dias J.J., Santos W.F., Lachat J.J., Bradford H.F., Coutinho-Netto J. Glutamate release in experimental ischaemia of the retina: An approach using microdialysis. J. Neurochem. 59:1992;358-363.
27. Lysko P.G., Feuerstein G. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: Protection by SKF 10,047. Neurosci. Lett. 120:1990;217-220.
28. Lysko P.G., Gagnon R.C., Yue T.-L., Gu J.-L., Feuerstein G. Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke. 23:1992;414-419.
29. Lysko P.G., Yue T.-L., Gu J.-L., Feuerstein G. Neuroprotective mechanism of (+)SKF 10,047 in vitro and in gerbil global brain ischemia. Stroke. 23:1992;1319-1324.
30. 2+ influx elicited by glutamate: Role in neuronal death. Mol. Pharmacol. 36:1989;106-112.
31. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
32. 1 receptor agonist. Eur. J. Pharmacol. 306:1996;271-279.
33. Maurice T., Hiramatsu M., Itoh J., Kameyama T., Hasegawa T., Nabeshima T. Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res. 647:1994;44-56.
34. McCann D.J., Weissman A.D., Su T.-P. Sigma-1 and sigma-2 sites in rat brain: Comparison of regional, ontogenetic, and subcellular patterns. Synapse. 17:1994;182-189.
35. Meldrum B. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin. Sci. 68:1985;113-122.
36. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:1990;379-387.
37. 3 dorsal hippocampus by sigma ligands. J. Pharmacol. Exp. Ther. 261:1992;123-130.
38. 3H ]-noradrenaline release in rat hippocampal slices Br. J. Pharmacol. 119:1996;65-72.
39. Neal M.J. Amino acid transmitter substances in the vertebrate retina. Gen. Pharmacol. 7:1976;321-332.
40. Neal M.J., Cunningham J.R., Hutsom P.H., Hogg J. Effects of ischaemia on neurotransmitter release from the isolated retina. J. Neurochem. 62:1994;1025-1033.
41. 2+ after exposure to glutamate receptor agonist. Exp. Brain Res. 73:1988;447-458.
42. Okuyama S., Imagawa Y., Ogawa S., Araki H., Ajima A., Tanaka M., Muramatsu M., Nakazato A., Yamaguchi K., Yoshida M., Otomo S. NE-100, a novel sigma receptor ligand: In vivo tests. Life Sci. 53:1993;285-290.
43. Okuyama S., Imagawa Y., Tomisawa K. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice. Neuropharmacology. 35:1996;467-474.
44. Pingping Z., Ogita K., Yoneda Y. Presence of the binding of a variety of ligands related to ionotropic excitatory amino acid receptors in rat retina. Brain Res. 576:1992;168-172.
45. Pontecorvo M.J., Karbon E.W., Goode S., Clissold D.B., Borosky S.A., Patch R.J., Ferkany J.W. Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents. Brain Res. Bull. 26:1991;461-465.
46. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.-P., Tam S.W., Taylor D.P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13:1992;85-86.
47. Rao T.S., Cler J.A., Mick S.J., Ragan D.M., Lanthorn T.H., Contreras P.C., Iyengar S., Wood P.L. Opipramol, a potent sigma ligand, is an anti-ischaemic agent: Neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurements. Neuropharmacology. 29:1990;1199-1204.
48. Sarantis M., Everett K., Attwell D. A presynaptic action of glutamate at the cone output synapse. Nature. 332:1988;451-453.
49. 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur. J. Pharmacol. 315:1996;1-10.
50. Senda T., Matsuno K., Mita S. The presence of σ receptor subtypes in bovine retinal membranes. Exp. Eye. Res. 64:1997;857-860.
51. Senda T., Matsuno K., Kobayashi T., Mita S. Reduction of the scopolamine-induced impairment of passive-avoidance performance by σ receptor agonist in mice. Physiol. Behav. 61:1997;257-264.
52. Siesjö B.K. Historical overview. Calcium, ischemia, and death of brain cells. Ann. NY Acad. Sci. 522:1988;638-661.
53. Simon R.P., Swan J.H., Griffiths T., Meldrum B.S. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 226:1984;850-852.
54. Steinfels G.F., Alberici G.P., Tam S.W., Cook L. Biochemical, behavioral, and electrophysiological actions of the selective sigma receptor ligand (+)-pentazocine. Neuropsychopharmacology. 1:1988;321-327.
55. Steinfels G.F., Tam S.W., Cook L. Electrophysiological effects of selective σ-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons. Neuropsychopharmacology. 2:1989;201-208.
56. 3H ]NE-100, a novel sigma-receptor ligand, to guinea-pig brain membranes Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;244-251.
57. Ujihara H., Akaike A., Tamura Y., Yokota T., Sasa M., Kashii S., Honda Y. Blockade of retinal NMDA receptors by sodium nitroprusside is probably due to nitric oxide formation. Jpn. J. Pharmacol. 61:1993;375-377.
58. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., De Costa B., Rice K.C. Sigma receptors: Biology and function. Pharmacol. Rev. 42:1990;355-402.
59. Wong E.H.F., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA. 83:1986;7104-7108.
60. Yoon Y.H., Marmor M.F. Dextromethrophan protects retina against ischemic injury in vivo. Arch. Ophthalmol. 107:1989;409-411.